Codon AG (CHIX:CNWKD) Change In Receivables : €0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Codon AG Change In Receivables?

Codon AG's change in receivables for the quarter that ended in Jun. 2022 was €0.00 Mil. It means Codon AG's Accounts Receivable stayed the same from Dec. 2021 to Jun. 2022 .

Codon AG's change in receivables for the fiscal year that ended in Dec. 2021 was €0.00 Mil. It means Codon AG's Accounts Receivable stayed the same from Dec. 2020 to Dec. 2021 .

Codon AG's Accounts Receivable for the quarter that ended in Jun. 2022 was €0.74 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Codon AG's Days Sales Outstanding for the six months ended in Jun. 2022 was 41.62.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Codon AG's liquidation value for the six months ended in Jun. 2022 was €-6.38 Mil.

Codon AG Change In Receivables Historical Data

The historical data trend for Codon AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG Change In Receivables Chart

Codon AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

Codon AG Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Codon AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Codon AG (CHIX:CNWKd) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Codon AG's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.743	/	3.258	*	91
=	41.62

2. In Ben Graham's calculation of liquidation value, Codon AG's accounts receivable are only considered to be worth 75% of book value:

Codon AG's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.697	-	8.969	+	0.75 * 0.743	+	0.5 * 0.661
=	-6.38

Codon AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Codon AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Codon AG (CHIX:CNWKD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Warthestrasse 21, Teltow, DEU, 14513

Website

http://www.codon.de

Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.

Codon AG (CHIX:CNWKD) Headlines

No Headlines